American pharmaceutical company Pfizer believes that a COVID-19 vaccine could be ready by the end of October 2020, reported The Times of Israel, citing Albert Bourla, the CEO of the firm.

 “If things go well, and the stars are aligned, we will have enough evidence of safety and efficacy so that we can… have a vaccine around the end of October,” Bourla was quoted as saying in the report.

Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech.

Source: cnbctv18.com